Clinical Trials Directory

Trials / Conditions / Spinocerebellar Degeneration

Spinocerebellar Degeneration

9 registered clinical trials studyying Spinocerebellar Degeneration — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingConfirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
NCT07040137
Kissei Pharmaceutical Co., Ltd.Phase 3
CompletedC-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
NCT04107740
HLB Pharmaceutical Co., Ltd.Phase 4
CompletedAn Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT02889302
Kissei Pharmaceutical Co., Ltd.Phase 3
CompletedA Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01970098
Kissei Pharmaceutical Co., Ltd.Phase 3
CompletedA 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01970137
Kissei Pharmaceutical Co., Ltd.Phase 3
CompletedPhase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT00863538
Kissei Pharmaceutical Co., Ltd.Phase 2
CompletedA Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01970124
Kissei Pharmaceutical Co., Ltd.Phase 3
CompletedA Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01004016
Kissei Pharmaceutical Co., Ltd.Phase 2
CompletedAn Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01970111
Kissei Pharmaceutical Co., Ltd.Phase 3